The Belay Group
The Belay Group is a privately held investment banking and strategic advisory firm headquartered in Charleston, South Carolina. It publicly describes a healthcare-services focus and offers M&A, capital raising, valuation, and strategic advisory services.
What stands out about The Belay Group
The Belay Group advises middle-market and emerging-growth healthcare companies on sell-side and buy-side M&A, capital raising, valuations, corporate strategy, and merger or joint-venture matters. Its public materials identify healthcare subsectors and selected transaction examples. The services page does not publish standard engagement-fee terms or quantitative eligibility thresholds; the company page does not state a specific geographic mandate; and the transaction page does not provide detailed terms for the named examples.[1][2][3][4][5]
What does The Belay Group do?
The Belay Group is a privately held investment banking firm headquartered in Charleston, South Carolina, and identifies belaygroup.com as its website. It describes itself as focused on healthcare services and serving middle-market and emerging-growth healthcare companies.
The firm states that it has more than 20 years of healthcare-services experience, has completed over 25 transactions, and has accumulated over $3bn in transaction value. These are firm-stated cumulative metrics.[1][2][4]
Publicly stated services include investment banking and strategic advisory, mergers and acquisitions, capital raising, corporate strategy, valuations, sell-side advisory and divestitures, buy-side advisory and acquisitions, and merger or joint-venture advisory.
An official presentation describes a one-stop-shop model covering strategy or consulting, growth capital, selling a business, and making an acquisition.[1][3][5]
Owners comparing advisory firms can also review Auxo’s M&A advisor vs. business broker vs. investment bank comparison, advisor-selection guide, and sell-side advisor evaluation framework.
What should a business owner evaluate before hiring The Belay Group?
Owners evaluating The Belay Group can clarify how the firm’s healthcare-services specialization applies to their subsector and transaction objective, including a sale, recapitalization, acquisition, capital raise, valuation, or strategic combination. The firm’s public sale-preparation discussion identifies financial reporting, back-office operations, ownership and economic structure, scale-building decisions, and tax planning as matters addressed in preparing provider groups for a sale process.
Before engagement, owners should request the proposed fee and expense provisions, confirm the transaction team’s specific experience, distinguish work completed by current personnel from work completed at predecessor firms, and ask for dated, non-confidential transaction references. They should also clarify the applicable buyer coverage, geographic reach, broker-dealer role, contracting entity, and any current revenue, EBITDA, transaction-size, or ownership criteria. The official company page does not state a specific geographic coverage mandate, and the cited services page does not state minimum revenue, EBITDA, transaction-size, ownership-structure, or other quantitative eligibility thresholds for prospective clients.[1][3][4][5][6]
What are the proposed retainer, success fee, minimum fee, tail, expense, and termination provisions
What transaction-size, revenue, EBITDA, ownership, or healthcare-subsector criteria does the firm currently prioritize
Which named transactions were completed by the current team while at The Belay Group, and which were completed at predecessor firms
What size transactions and clients does The Belay Group focus on?
The Belay Group states that its healthcare focus spans physician services and practice management, outsourced services and healthcare IT, pharma and laboratory services, and facilities and alternate-site care.
Examples identified in the firm’s public materials include urgent care, physical therapy, dermatology, podiatry, multispecialty practices, revenue cycle and EMR, digital health, telemedicine, healthcare staffing, specialty pharmacy, infusion services, diagnostic laboratories, post-acute care, mental health, specialty hospitals, ambulatory surgery centers, and home care.[4]
The official transaction section identifies NextCare Urgent Care, UCHealth, MultiCare, and Hospital Corporation of America as transaction examples. The official transaction page does not provide transaction dates, transaction values, buyer or investor identities, consideration terms, or deal structures for those examples.
A separate official presentation states that urgent-care-specific engagements included more than a dozen engagements, approximately $500 million of combined enterprise value in completed transactions, and a 90%+ completion rate. It notes that the examples include transactions managed by Belay team members as lead banker while at Belay and predecessor firms.[4][5]
The firm’s stated transaction services include sell-side advisory and divestitures, buy-side advisory and acquisitions, capital raising, valuations, and merger or joint-venture advisory. Its materials also describe work involving strategic buyers, private equity, venture capital, private debt, revolving-credit providers, and joint-venture partners.[1][3][5]
What does The Belay Group publicly disclose about fees, process and engagement terms?
The services page does not publish a universal success-fee percentage, minimum fee, retainer, tail period, termination schedule, or other standard engagement-fee terms.
The official transaction page does not provide transaction dates, transaction values, buyer or investor identities, consideration terms, or deal structures for the named transaction examples. The official company page identifies Charleston, South Carolina as headquarters but does not state a specific geographic coverage mandate or limitation for client engagements. The official services page does not state minimum revenue, EBITDA, transaction-size, ownership-structure, or other quantitative eligibility thresholds for prospective clients.[1][3][4]
The firm’s official website states that securities transactions are conducted through TCFG Wealth Management, LLC, identified there as a FINRA, MSRB, and SIPC member. The same disclosure states that members of The Belay Group are registered representatives of that broker-dealer.
This disclosure establishes an identified broker-dealer affiliation or transaction-processing relationship; it does not by itself establish a separate firm-level registration status for The Belay Group.[4]
A 2024 interview with Managing Partner Marc Anderson discusses preparing healthcare provider groups for a sale process. Topics include professionalizing back-office operations and financial reporting, ownership structure and economics, consolidation for scale, and tax planning.[6]
Questions to ask before hiring The Belay Group
What are the proposed retainer, success fee, minimum fee, tail, expense, and termination provisions?
What transaction-size, revenue, EBITDA, ownership, or healthcare-subsector criteria does the firm currently prioritize?
Which named transactions were completed by the current team while at The Belay Group, and which were completed at predecessor firms?
Can the firm provide dated, non-confidential transaction references and clarify buyer type, transaction structure, and consideration terms?
How is TCFG Wealth Management, LLC involved in the proposed engagement, and which legal entity will contract with the owner?
What geographic buyer coverage and international capability would apply to the engagement?
Sources & research notes
- Official website / firm overview
- Identity / organization record
- Services / capabilities
- Industry / market focus
- Transaction / portfolio evidence
- Public Process
How this profile was researched
Auxo profiles are prepared from publicly available primary and authoritative sources and reviewed for entity identity, factual support and disclosure consistency. When a fact cannot be supported by the reviewed public record, the profile identifies it as something to confirm directly rather than inferring it.
Independent research profile
This profile was prepared by Auxo Capital Advisors from publicly available information believed to be reliable and is provided solely for informational and educational purposes. It is not an endorsement, recommendation, ranking, solicitation, or representation regarding the profiled firm, its services, qualifications, transaction experience, regulatory status, financial condition, or suitability for any particular person, company, transaction, or investment.
Information obtained from third-party and public sources may be incomplete, inaccurate, outdated, or subject to change, and Auxo Capital Advisors makes no representation or warranty, express or implied, as to its accuracy, completeness, or timeliness. Readers should conduct their own independent diligence and consult appropriate professional advisers before engaging any advisor, intermediary, investor, lender, acquirer, or other transaction counterparty.
Broker-dealer and securities disclosure
Auxo Capital Advisors is an affiliate of Weild & Co., Member FINRA | SIPC. Securities-related activities and securities transactions are conducted through Weild & Co.
Nothing contained on this page constitutes an offer to sell, an offer to purchase, or a solicitation of an offer to buy or sell any security, investment product, or financial instrument. Nothing on this page constitutes investment advice, a recommendation regarding any security, or a recommendation to enter into any transaction with the profiled firm or any other party.
Any securities transaction, capital-raising engagement, investment-banking engagement, or other securities-related activity involving Auxo Capital Advisors or Weild & Co. is subject to applicable regulatory requirements, internal review and approval, suitability and other applicable diligence requirements, and the terms of a separate written engagement or transaction agreement, as applicable.
Inclusion of a third-party firm in this directory does not imply affiliation with, sponsorship by, endorsement by, or any other relationship with Auxo Capital Advisors or Weild & Co. unless expressly stated otherwise.